Concepedia

Publication | Open Access

Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma

DOIFull Paper Access

84

Citations

34

References

2008

Year

Jean‐Yves Blay, Margaret von Mehren, Brian L. Samuels, Michael Fanucchi, Isabelle Ray‐Coquard, B. Buckley, Leen Gilles, Claudia Lebedinsky, Yusri Elsayed, Axel Le Cesne
Clinical Cancer Research

Abstract

The combination of doxorubicin 60 mg/m(2) followed by trabectedin 1.1 mg/m(2) every 21 days is safe and active in patients with soft-tissue sarcoma.

References

YearCitations

Page 1